Cardiology and Heart Failure

Cardio-Oncology

Cardio-oncology is the intersection of heart conditions in patients who have been treated for cancer. New insights into how cancer therapies impact cardiovascular homeostasis and long-term effects on cancer survivors. In view of trends, as well as the cardiovascular toxicity potential of radiation and chemotherapy, cancer patients are exposed to cardiovascular morbidity and mortality more than ever before. Anticancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure (HF), independently from the direct myocardial or pericardial damage that might occur. Moreover, cancer is generally associated with a hypercoagulable state, which increases the risk of acute thrombotic events.